I’m afraid the herd is quite thinned this week. In my mind, the big news of the week was from the Hill – the Kennedy/Enzi legislation which I posted about yesterday. There was not a lot going on at the FDA.
- Families USA Study on Drug Prices and Medicare Part D – A study released this week by Families USA states that drug prices have risen since the advent of Medicare Part D. This serves as a double blow – one to the image of the industry at a time when reform movements are afoot and – two to the beleaguered image of the prescription drug benefit for seniors, on which the jury is still out, but which has also had a rocky start.
- FDA Issues Guide on Allergens in the Food Supply – While this doesn’t sound particularly headline grabbing, it is an interesting topic. Judge for yourself if it does the job by clicking here.
- FDA Still Doesn’t Post Janet Woodcock’s Testimony – For all the talk of promoting transparency, the agency still has not posted this testimony. Looks like those of us who are interested are going to have to file a FOIA to get it. I will be doing so this week and will keep you posted on the progress.
Have a good weekend everyone!